In addition, because combination of the AMPK inhibitor with the RAF inhibitor also dramatically reduces the drug-resistant clones derived from BRAFV600E-harboring cancer cells, it will improve the treatment of this type of cancers with RAF inhibitors. This evidence concerns the gene RAF1 and cancer.